| |
| |
|
| Insider
Information: |
Scranton Richard |
| Relationship: |
Chief Scientific Officer |
| City: |
Parsippany |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
16,061 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$437,020 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
16,061 |
|
|
| Total
Value |
$437,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
Chief Scientific Officer |
2019-11-08 |
16,061 |
2017-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2019-11-08 |
4 |
AS |
$45.00 |
$875,160 |
D/D |
(19,448) |
16,061 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2019-11-08 |
4 |
OE |
$10.81 |
$279,393 |
D/D |
19,448 |
35,509 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
16,061 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2019-06-05 |
4 |
AS |
$43.50 |
$178,959 |
D/D |
(4,114) |
11,061 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2019-06-04 |
4 |
AS |
$42.66 |
$210,662 |
D/D |
(4,926) |
15,175 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2019-06-03 |
4 |
AS |
$43.21 |
$670,187 |
D/D |
(15,510) |
20,101 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2019-06-03 |
4 |
OE |
$10.52 |
$166,790 |
D/D |
15,510 |
35,611 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2018-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,875 |
20,101 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2018-06-04 |
4 |
S |
$33.02 |
$45,138 |
D/D |
(1,367) |
12,226 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific OfficerOffice |
• – – |
2017-06-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,843 |
|
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Scientific Officer |
• – – |
2017-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
13,593 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
